HuGE Literature Finder
Records
1
-
30
| Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer. JAMA network open 2022 Dec 5 (12): e2245836. Liu Ze-Xian, Zhang Xiao-Long, Zhao Qi, Chen Yungchang, Sheng Hui, He Cai-Yun, Sun Yu-Ting, Lai Ming-Yu, Wu Min-Qing, Zuo Zhi-Xiang, Wang Wei, Zhou Zhi-Wei, Wang Feng-Hua, Li Yu-Hong, Xu Rui-Hua, Qiu Miao-Zh |
| Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute 2022 Oct . DeVries Amber A, Dennis Joe, Tyrer Jonathan P, Peng Pei-Chen, Coetzee Simon G, Reyes Alberto L, Plummer Jasmine T, Davis Brian D, Chen Stephanie S, Dezem Felipe Segato, Aben Katja K H, Anton-Culver Hoda, Antonenkova Natalia N, Beckmann Matthias W, Beeghly-Fadiel Alicia, Berchuck Andrew, Bogdanova Natalia V, Bogdanova-Markov Nadja, Brenton James D, Butzow Ralf, Campbell Ian, Chang-Claude Jenny, Chenevix-Trench Georgia, Cook Linda S, DeFazio Anna, Doherty Jennifer A, Dörk Thilo, Eccles Diana M, Eliassen A Heather, Fasching Peter A, Fortner Renée T, Giles Graham G, Goode Ellen L, Goodman Marc T, Gronwald Jacek, , , Håkansson Niclas, Hildebrandt Michelle A T, Huff Chad, Huntsman David G, Jensen Allan, Kar Siddhartha, Karlan Beth Y, Khusnutdinova Elza K, Kiemeney Lambertus A, Kjaer Susanne K, Kupryjanczyk Jolanta, Labrie Marilyne, Lambrechts Diether, Le Nhu D, Lubi?ski Jan, May Taymaa, Menon Usha, Milne Roger L, Modugno Francesmary, Monteiro Alvaro N, Moysich Kirsten B, Odunsi Kunle, Olsson Håkan, Pearce Celeste L, Pejovic Tanja, Ramus Susan J, Riboli Elio, Riggan Marjorie J, Romieu Isabelle, Sandler Dale P, Schildkraut Joellen M, Setiawan V Wendy, Sieh Weiva, Song Honglin, Sutphen Rebecca, Terry Kathryn L, Thompson Pamela J, Titus Linda, Tworoger Shelley S, Van Nieuwenhuysen Els, Edwards Digna Velez, Webb Penelope M, Wentzensen Nicolas, Whittemore Alice S, Wolk Alicja, Wu Anna H, Ziogas Argyrios, Freedman Matthew L, Lawrenson Kate, Pharoah Paul D P, Easton Douglas F, Gayther Simon A, Jones Michelle |
| Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. European urology 2022 Oct . Loehr Andrea, Hussain Arif, Patnaik Akash, Bryce Alan H, Castellano Daniel, Font Albert, Shapiro Jeremy, Zhang Jingsong, Sautois Brieuc, Vogelzang Nicholas J, Chatta Gurkamal, Courtney Kevin, Harzstark Andrea, Ricci Francesco, Despain Darrin, Watkins Simon, King Charmin, Nguyen Minh, Simmons Andrew D, Chowdhury Simon, Abida Wass |
| Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations. British journal of cancer 2022 Oct . Jacot William, Lusque Amélie, Vicier Cécile, Mailliez Audrey, de La Motte Rouge Thibault, Cabel Luc, Levy Christelle, Patsouris Anne, Desmoulins Isabelle, Uwer Lionel, Thery Jean-Christophe, Robain Mathieu, Caron Olivier, Tredan Olivier, Filleron Thomas, Frenel Jean-Sébastien, Delaloge Suzet |
| Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype. Breast cancer research and treatment 2022 Oct 195 (3): 431-439. Zang Fan, Ding Xinyun, Chen Jiuan, Hu Li, Sun Jie, Zhang Juan, Xu Ye, Yao Lu, Xie Yunt |
| Analysis of rare disruptive germline mutations in 2,135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes. Annals of oncology : official journal of the European Society for Medical Oncology 2022 Sep . Loveday C, Garrett A, Law P, Hanks S, Poyastro-Pearson E, Adlard J W, Barwell J, Berg J, Brady A F, Brewer C, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison P J, Paterson J, Porteous M, Rogers M T, Walker L, , Eccles D, Evans D G, Snape K, Hanson H, Houlston R S, Turnbull |
| BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers 2022 Sep 14 (19): . Pavese Francesco, Capoluongo Ettore Domenico, Muratore Margherita, Minucci Angelo, Santonocito Concetta, Fuso Paola, Concolino Paola, Di Stasio Enrico, Carbognin Luisa, Tiberi Giordana, Garganese Giorgia, Corrado Giacomo, Di Leone Alba, Generali Daniele, Fragomeni Simona Maria, D'Angelo Tatiana, Franceschini Gianluca, Masetti Riccardo, Fabi Alessandra, Mulè Antonino, Santoro Angela, Belli Paolo, Tortora Giampaolo, Scambia Giovanni, Paris I |
| Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient HCC. Hepatology (Baltimore, Md.) 2022 Sep . An Jihyun, Oh Ji-Hye, Oh Bora, Oh Yoo-Jin, Ju Jin-Sung, Kim Wonkyung, Kang Hyo Jung, Sung Chang Ohk, Shim Ju Hy |
| Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan. HPB : the official journal of the International Hepato Pancreato Biliary Association 2022 Sep . Muhammad Noor, Sadaqat Rida, Naeemi Humaira, Masood Iqra, Hassan Usman, Ijaz Bushra, Hanif Faisal, Syed Aamir A, Yusuf Muhammed A, Rashid Muhammad |
| Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case-Control Studies. Cancers 2022 Sep 14 (19): . Bara?ska Agnieszka, Kanadys Wies? |
| Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants. Cancer cell 2022 Sep . Mukherjee Semanti, Carrot-Zhang Ji |
| Analyses of rare predisposing variants of lung cancer in 6,004 whole genomes in Chinese. Cancer cell 2022 Aug . Wang Cheng, Dai Juncheng, Qin Na, Fan Jingyi, Ma Hongxia, Chen Congcong, An Mingxing, Zhang Jing, Yan Caiwang, Gu Yayun, Xie Yuan, He Yuanlin, Jiang Yue, Zhu Meng, Song Ci, Jiang Tao, Liu Jia, Zhou Jun, Wang Nanxi, Hua Tingting, Liang Shuang, Wang Lu, Xu Jing, Yin Rong, Chen Liang, Xu Lin, Jin Guangfu, Lin Dongxin, Hu Zhibin, Shen Hongbi |
| Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers. Breast cancer research and treatment 2022 Aug . Nemati Shafaee Maryam, Goutsouliak Kristina, Lin Heather, Bevers Therese B, Gutierrez-Barrera Angelica, Bondy Melissa, Arun Ba |
| BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer. Hereditary cancer in clinical practice 2022 Aug 20 (1): 29. El Ansari Fatima Zahra, Jouali Farah, Fekkak Rim, Bakkach Joaira, Ghailani Nourouti Naima, Barakat Amina, Bennani Mechita Mohcine, Fekkak Jam |
| Frequency of germline genetic variants in women with a personal or family history of breast cancer from Brazil. Molecular biology reports 2022 Aug . Pereira Júlia Zanon, Carneiro Juliana Garcia, Vieira Mariana Sousa, Valente Bruna Mattioly, de Oliveira Pâmella Zorzan, Mello Carolina Lins, de Campos Caroline Leonel Vasconcelos, Gomes Karina Bra |
| Genetic and clinical characteristics of BRCA-associated hereditary breast cancer in the West region of Kazakhstan. Carcinogenesis 2022 Aug . Aitmagambetova Marzhan A, Smagulova Gaziza A, Tuhvatshin Rustem R, Zheksenova Azhar N, Amanzholkyzy Ain |
| Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. BMC cancer 2022 Aug 22 (1): 842. Zhang Yunuo, Wu Heming, Yu Zhikang, Li Liang, Zhang Jinhong, Liang Xinhong, Huang Qingy |
| Heterozygous BRCA1/2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents with Cancer. Journal of the National Cancer Institute 2022 Aug . Kratz Christian P, Smirnov Dmitrii, Autry Robert, Jäger Natalie, Waszak Sebastian M, Großhennig Anika, Berutti Riccardo, Wendorff Mareike, Hainaut Pierre, Pfister Stefan M, Prokisch Holger, Ripperger Tim, Malkin Dav |
| Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens. Urologic oncology 2022 Aug . Papadopoulou Kyriaki, Koliou Georgia-Angeliki, Tsimiliotis Dimitrios, Kotoula Vassiliki, Foukas Periklis, Goussia Anna, Tsiatas Marinos, Visvikis Anastasios, Chatzopoulos Kyriakos, Nifora Martha, Charchanti Antonia, Koumarianou Anna, Christodoulou Christos, Pectasides Dimitrios, Psyrri Amanda, Fostira Florentia, Fountzilas George, Samantas Epaminont |
| Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer. British journal of cancer 2022 Aug . Kimura Hiroko, Mizuno Kei, Shiota Masaki, Narita Shintaro, Terada Naoki, Fujimoto Naohiro, Ogura Keiji, Hatano Shotaro, Iwasaki Yusuke, Hakozaki Nozomi, Ishitoya Satoshi, Sumiyoshi Takayuki, Goto Takayuki, Kobayashi Takashi, Nakagawa Hidewaki, Kamoto Toshiyuki, Eto Masatoshi, Habuchi Tomonori, Ogawa Osamu, Momozawa Yukihide, Akamatsu Shusu |
| Breast cancer in East Africa: Prevalence and spectrum of germline SNV/indel and CNVs in BRCA1 and BRCA2 genes among breast cancer patients in Tanzania. Cancer medicine 2022 Jul . Rweyemamu Linus P, Gülta?lar Bü?ra K, Akan Gokce, Dharsee Nazima, Namkinga Lucy A, Lyantagaye Sylvester L, Yaz?c? Hülya, Atalar Fatmah |
| Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Jul . Siegmund Stephanie E, Manning Danielle K, Davineni Phani K, Dong F |
| LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma. Medicine 2022 Jul 101 (26): e29763. Yu Ge, Mu Han, Fang Feng, Zhou Hongyuan, Li Huikai, Wu Qiang, Xiong Qingqing, Cui Yunlo |
| Predominance of Cancers 2022 Jul 14 (13): . Pujol Pascal, Yauy Kevin, Coffy Amandine, Duforet-Frebourg Nicolas, Gabteni Sana, Daurès Jean-Pierre, Penault Llorca Frédérique, Thomas Frédéric, Hughes Kevin, Turnbull Clare, Galibert Virginie, Rideau Chloé, Corsini Carole, Collet Laetitia, You Benoit, Geneviève David, Philippe Nicol |
| Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan. Familial cancer 2022 Jul . Rashid Muhammad Usman, Muhammad Noor, Shehzad Umara, Khan Faiz Ali, Loya Asif, Hamann U |
| Screening of BRCA1 (c.5177_5180delGAAA rs80357867 and c.4986+6T>C rs80358086) and the BRCA2 (c.6445_6446delAT rs80359592) Genes for Breast Cancer Prevention in Burkina Faso. Ethiopian journal of health sciences 2022 Jul 32 (4): 699-708. Kiendrebeogo Isabelle T, Zoure Abdou A, Zongo Fabienne I, Ouedraogo Serge Y, Sawadogo Alexis Y, Amegnona Jospin, Sombie Herman K, Bazie Jean T Valérie Elvira, Sorgho Pegdwendé A, Yonli Albert T, Ouedraogo Marie N Lamoussa, Obiri-Yeboah Dorcas, Zongo Nayi, Bambara Hierrhum A, Simpore Jacqu |
| Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing. World journal of clinical cases 2022 May 10 (15): 4761-4775. Zeng Hui-Hui, Yang Ze, Qiu Ye-Bei, Bashir Shoaib, Li Yin, Xu Me |
| Clinical characteristics of patients with Breast and / or Ovarian Cancer with mutations in the BRCA1 and BRCA2 genes in Córdoba, Argentina Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 2022 09 79 (3): 228-234. Martin Claudia Alejandra, Suárez Villasmil Lourdes, Sembaj Adela, Gomez Balangione Fabian, Zunino Silvia, Montes Cecilia Del Carmen, Borello Adriana, Del Castillo Andres, Zeballos Maximiliano, Rossi Norma Tere |
| Prevalence and Factors Associated with BRCA1/2 Gene Mutation in Chinese Populations with Breast Cancer. International journal of general medicine 2022 15 6783-6789. Huang Guoding, Lu Hongquan, Chen Qizhu, Huang Xinti |
| Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study. PloS one 2022 17 (9): e0275015. Heemskerk-Gerritsen Bernadette A M, Hollestelle Antoinette, van Asperen Christi J, van den Beek Irma, van Driel Willemien J, van Engelen Klaartje, Gómez Garcia Encarna B, de Hullu Joanne A, Koudijs Marco J, Mourits Marian J E, Hooning Maartje J, Boere Ingrid |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: